Brief: Kuros FY Revenues Up At CHF 4.0 Million

Kuros Biosciences AG

18/03/2021 06:05

March 18 (Reuters) - KUROS BIOSCIENCES AG  KURN.S :
    * FY REVENUES INCREASED BY 58% TO CHF 4.0 MILLION
    * FY NET OPERATING COSTS INCREASED TO CHF 13.4 MILLION
(2019: CHF
11.7 MILLION)
    * FY OTHER INCOME AMOUNTED TO CHF 0.3 MILLION (2019: CHF 0.3
MILLION)
    * IS FINANCED TO ACCELERATE COMMERCIAL ROLL-OUT OF MAGNETOS
IN
U.S. AND TO COMPLETE PHASE II CLINICAL STUDY OF FIBRIN-PTH IN
SPINE, WITH FIRST (INTERIM) DATA EXPECTED TO BE AVAILABLE BY
EARLY 2022
    * AND FULL (1-YEAR ENDPOINT) DATA IN SECOND HALF OF 2022

Source text for Eikon:  ID:nTENnobzaa 
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))